Global Brain Mapping Instruments Market Report 2026–2035: Key Forecasts and Growth Areas
Uncover key drivers, emerging technologies, and competitive movements shaping the ready-to-use pharmaceutical packaging market from 2026–2035 with trusted insights from The Business Research Company
What level of growth is expected in the Brain Mapping Instruments Market between 2026 and 2030?
The brain mapping instruments market has experienced substantial growth in recent years. Projections indicate a rise from $2.42 billion in 2025 to $2.58 billion in 2026, at a compound annual growth rate (CAGR) of 6.6%. This historical expansion is attributable to factors such as the increase in neurological disorder diagnosis programs, the growing use of EEG and CT-based brain mapping systems, the early integration of neuroimaging tools within hospital and research settings, the broadening application of brain activity monitoring in clinical neurology, and increased investment in neuroscience research infrastructure.
The brain mapping instruments market is anticipated to experience substantial expansion over the next few years. It is projected to climb to $3.33 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This expected increase during the forecast period stems from factors such as a heightened demand for fMRI and PET-based functional brain mapping, the growing adoption of hybrid and high-resolution imaging systems, an increased preference for non-invasive mapping solutions in ambulatory environments, the rising integration of multimodal brain analysis tools, and the broadening applications of brain mapping in precision medicine and neurotherapeutics. Significant trends for this period encompass the increasing embrace of advanced neuroimaging and brain activity monitoring technologies, the expanded deployment of brain mapping instruments in clinical diagnosis and treatment planning, the widening scope of brain mapping applications across neuroscience and cognitive research, a surging demand for non-invasive and patient-friendly brain mapping procedures, and a concentrated effort on boosting imaging accuracy, data quality, and diagnostic effectiveness.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18270&type=smp
Which Drivers Are Expected To Impact The Brain Mapping Instruments Market During The Forecast Period?
The anticipated rise in neurological disorder cases is set to boost the expansion of the brain mapping instrument market in the future. These disorders encompass conditions impacting the brain, spinal cord, and nerves, manifesting in symptoms like impaired movement, cognitive deterioration, and sensory disturbances, with examples such as Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, and stroke. The growing occurrence of neurological disorders is attributable to factors including an aging population, increased urbanization, shifts in lifestyle, enhanced diagnostic methods, and various environmental and infectious risk factors. Brain mapping instruments play a crucial role in both clinical settings and research, offering profound understanding of neurological disorders and aiding in the development of tailored treatment approaches. For example, data from March 2023, provided by the Alzheimer’s Association, a US-based non-profit voluntary health organization, indicated that approximately 6.7 million Americans aged 65 and older in the United States were affected by Alzheimer’s dementia, a form of neurological disorder. Furthermore, projections suggest that by 2060, this figure for individuals aged 65 and older with Alzheimer’s dementia will climb to 13.8 million. Consequently, the rising incidence of neurological disorders is a significant factor driving the expansion of the brain mapping instrument market.
How Is The Brain Mapping Instruments Market Divided Into Segments?
The brain mapping instruments market covered in this report is segmented –
1) By Product: Computed Axial Tomography (CAT), Positron Emission Tomography, Electroencephalography (EEG), Functional Near-Infrared Spectroscopy (FNIRS), Functional Magnetic Resonance Imaging (FMRI), Other Products
2) By Procedure: Devices For Invasive Procedures, Devices For Non-invasive Procedures
3) By End User: Hospitals, Ambulatory Centers
Subsegments:
1) By Computed Axial Tomography (CAT): Conventional CT Scanners, High-Resolution CT Scanners, Portable CT Scanners
2) By Positron Emission Tomography (PET): PET Scanners (Standalone), Hybrid PET/CT Scanners, PET/MRI Scanners
3) By Electroencephalography (EEG): Digital EEG Systems, Ambulatory EEG Systems, Video EEG Monitoring Systems
4) By Functional Near-Infrared Spectroscopy (FNIRS): Continuous Wave Fnirs Systems, Frequency Domain Fnirs Systems, Hybrid Fnirs Systems
5) By Functional Magnetic Resonance Imaging (FMRI): Resting-State Fmri, Task-Based Fmri, High-Field MRI Systems
6) By Other Products: Magnetoencephalography (MEG) Systems, Near-Infrared Spectroscopy (NIRS) Devices, Transcranial Magnetic Stimulation (TMS) Systems
Which Competitive Trends Are Impacting The Structure Of The Brain Mapping Instruments Market?
Leading companies operating in the brain mapping instruments market are increasingly concentrating on adaptive neuromodulation featuring sensing capabilities, such as BrainSense-enabled closed-loop deep brain stimulation (DBS). This approach incorporates real-time brain signal detection to customize stimulation therapy. BrainSense technology serves as a neuro-interface built into DBS systems, which records local field potentials (LFPs) from specific brain regions, interprets these signals, and dynamically adjusts electrical stimulation according to a patient’s neural activity. This process optimizes therapeutic results and minimizes potential side effects. For example, in February 2025, Medtronic, a US-based medical-technology company, unveiled its BrainSense Adaptive DBS system following FDA approval. This system offers features like real-time self-adjusting stimulation, a BrainSense Electrode Identifier to quickly ascertain the optimal electrode contact, and personalized closed-loop therapy that adapts both within clinical environments and throughout a patient’s daily existence.
Which Key Players Are Driving Competition In The Brain Mapping Instruments Market?
Major companies operating in the brain mapping instruments market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Elekta AB, Nihon Kohden Corporation, Brainlab AG, Natus Medical Incorporated, Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, Gowerlabs Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/brain-mapping-instruments-global-market-report
Which Region Is Projected To Lead The Brain Mapping Instruments Market During The Forecast Period?
North America was the largest region in the brain mapping instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain mapping instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Brain Mapping Instruments Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18270&type=smp
Browse Through More Reports Similar to the Global Brain Mapping Instruments Market 2026, By The Business Research Company
Brain And Neuroimaging Devices Global Market Report 2026
Brain Monitoring Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report
Brain Health Supplements Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/brain-health-supplements-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
